There's a lot of tips and tricks to get the best 3D print possible, and one of the most useful you may not have heard of are ...
Trump and Netanyahu may deserve each other. But in the battle against Iran and its proxies, and in the struggle for the ...
News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to ...
A new book argues that rising faculty no-confidence votes signal deep campus tensions, as seen at University of ...
A new documentary about Saurabh Netravalkar isn’t really about cricket. It’s about what happens when someone chooses the ...
Aaron Schock traded congressional disgrace for what he said was his shot at a Venezuelan gold mine — and the chance to remake ...
The next, the Prime Minister was in New York to sell CEOs and fund managers on investing in Canada, touting this country as ...
News builds on previously announced positive topline results from SYNCHRONIZE-1 76-week trial, which met its primary endpoints and showed up to 16.6% weight loss with survodutide, a novel glucagon/GLP ...
Company announcement No. 21 / 2026Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and ...
Following in the footsteps of shows like The Twilight Zone, animation has taken advantage of the anthology format to deliver ...
The Globe and Mail sits down with Marie-Philippe Bouchard, president and CEO of the Crown corporation to talk streaming, ...
Why the US midterms — and the 2028 election — aren’t going to play out the way you think - IN FOCUS: Holly Baxter speaks to ...